Comparison of 2 informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE

Alzheimer Disease and Associated Disorders

Volumn 28, Issue 2, 2014, Pages 156-161

  Razavi, Mehrdad ^a   Tolea, Magdalena I ^c   Margrett, Jennifer ^b   Martin, Peter ^b   Oakland, Andrew ^a   Tscholl, David W ^a   Ghods, Sarah ^a   Mina, Mazdak ^a   Galvin, James E ^c  

^a McFarland Clinic   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AD8; Dementia; IQCODE; Mild cognitive impairment; Screening

Indexed keywords

AD8 QUESTIONNAIRE; AGED; AGING; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INFORMANT QUESTIONNAIRE ON COGNITIVE DECLINE IN THE ELDERLY; LIKERT SCALE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PUBLIC HEALTH; QUESTIONNAIRE; SCREENING TEST; UNITED STATES; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; DEVICES; MASS SCREENING; MIDDLE AGED; PSYCHOMETRY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; QUESTIONNAIRES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84901603810     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000008     Document Type: Article

References (42)

1. Connolly A, Gaehl E, Martin H, et al. Underdiagnosis of dementia in primary care: variations in the observed prevalence and comparisons to the expected prevalence. Aging Ment Health. 2011;15:978-984.
2. Galvin JE, Meuser TM, Morris JC. Improving physician awareness of Alzheimer disease and enhancing recruitment: the Clinician Partners Program. Alzheimer Dis Assoc Disord. 2012;26:61-67.
3. Galvin JE. Dementia screening, biomarkers and protein misfolding: implications for public health and diagnosis. Prion. 2011;5:16-21.
4. Doody RS, Ferris SH, Salloway S, et al. Identifying amnestic mild cognitive impairment in primary care: A feasibility study. Clin Drug Investig. 2011;31:483-491.
5. Galvin JE, Roe C, Coats M, et al. The AD8: A brief informant interview to detect dementia. Neurology. 2005;65:559-564. (Pubitemid 41170715)
6. Carpenter CR, Bassett ER, Fischer GM, et al. Four sensitive screening tools to detect cognitive dysfunction in geriatric emergency department patients: brief Alzheimer's Screen, Short Blessed Test, Ottawa 3DY, and the caregiver-completed AD8. Acad Emerg Med. 2011;18:374-384.
7. Jessen F, Wiese B, Bickel H, et al. Prediction of dementia in primary care patients. PLoS One. 2011;6:e16852.
8. Damian AM, Jacobson SA, Hentz JG, et al. The Montreal Cognitive Assessment and the Mini-Mental State Examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord. 2011;31:126-131.
9. Galvin JE, Roe CM, Xiong C, et al. The validity and reliability of the AD8 informant interview for dementia. Neurology. 2006;67:1942-1948. (Pubitemid 44967368)
10. Galvin JE, Roe CM, CoatsMA, et al. Patients rating of cognitive ability: using the AD8, a brief informant interview as a self-rating tool to detect dementia. Arch Neurol. 2007;64:725-730. (Pubitemid 46795172)
11. Galvin JE, Roe CM, Morris JC. Evaluation of cognitive impairment in the older adult: combining brief informant and performance measures. Arch Neurol. 2007;64:718-724. (Pubitemid 46789838)
12. Carr DB, Gray S, Baty J, et al. The value of informant versus individual's complaints of memory impairment in early dementia. Neurology. 2000;55:1724-1726.
13. Jorm AF, Christensen H, Henderson AS, et al. Informant ratings of cognitive decline of elderly people: relationship to longitudinal change on cognitive tests. Age Ageing. 1996;25:125-129. (Pubitemid 26091165)
14. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414. (Pubitemid 23346995)
15. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19:1015-1022. (Pubitemid 20012268)
16. Jorm AF, Scott R, Cullen JS, et al. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med. 1991;21:785-790.
17. Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): A review. Int Psychogeriatr. 2004; 16:275-293. (Pubitemid 39441493)
18. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270-279.
19. Galvin JE, Fagan AM, Holtzman DM, et al. Relationship of dementia screening tests with biomarkers of Alzheimer's Disease. Brain. 2010;133:3290-3300.
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
21. Sunderland T, Hill JL, Mellow AM, et al. Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37:725-729. (Pubitemid 19199790)
22. Borson S, Scanlan JM, Chen P, et al. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc. 2003;51:1451-1454. (Pubitemid 37259876)
23. McCarten JR, Anderson P, Kuskowski MA, et al. Screening for cognitive impairment in an elderly veteran population: Acceptability and results using different versions of the Mini- Cog. J Am Geriatr Soc. 2011;59:309-313.
24. Troyer AK, Moscovitch M, Winocur G, et al. Clustering and switching on verbal fluency tests in Alzheimer's and PD disease. J Int Neuropsychol Soc. 1998;4:137-143. (Pubitemid 28156088)
25. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246. (Pubitemid 39222993)
26. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944. (Pubitemid 14076461)
27. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-1872. (Pubitemid 43970103)
28. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43:250-260. (Pubitemid 23060253)
29. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol. 2005;4:771-780. (Pubitemid 41457293)
30. Brown CD, Davis HT. Receiver operating characteristics curves and related decision measures: A tutorial. Chemometrics Int Lab Syst. 2006;80:24-38. (Pubitemid 43052337)
31. Zhou XH, Obuchowski NA, McClish DK. Statistical Methods in Diagnostic Medicine. 1st ed. New York: John Wiley & Sons; 2002: 15-164.
32. McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002;17:646-649.
33. Espino DV, Lichtenstein MJ, Palmer RF, et al. Evaluation of the Mini-Mental State Examination's internal consistency in a community-based sample of Mexican-American and European- American elders: results from the San Antonio longitudinal study of aging. J Am Geriatr Soc. 2004;52:822-827. (Pubitemid 38596507)
34. Parker C, Philp I. Screening for cognitive impairment among older people in black and minority ethnic groups. Age Ageing. 2004;33:447-452. (Pubitemid 39214271)
35. National Guideline Clearinghouse (NGC). Guideline synthesis: diagnosis and assessment of Alzheimer's disease and related dementias. Agency for Healthcare Research and Quality, 2006. Available at: http://www.guideline.gov. Accessed March 13, 2013.
36. Boustani MA, Justiss MD, Frame A, et al. Caregiver and noncaregiver attitudes toward dementia screening. J Am Geriatr Soc. 2011; 59: 681-686.
37. Galvin JE, Fu Q, Nguyen JT, et al. Psychosocial determinants of intention to screen for Alzheimer Disease. Alzheimer Dement. 2008;4:353-360.
38. Sikkes SA, van den Berg MT, Knol DL, et al. How useful is the IQCODE for discriminating between Alzheimer's disease, mild cognitive impairment and subjective memory complaints? Dement Geriatr Cogn Disord. 2010;30:411-416.
39. Farias ST, Mungas D, Reed BR, et al. MCI is associated with deficits in everyday functioning. Alzheimer Dis Assoc Disord. 2006;20:217-223. (Pubitemid 44900934)
40. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263-269.
41. Holsinger T, Deveau J, Boustani M, et al. Does this patient have dementia? JAMA. 2007;297:2391-2404. (Pubitemid 46883752)
42. Cordell CB, Borson S, Boustani M, et al. Medicare Detection of Cognitive Impairment Workgroup. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement. 2013;9:141-150.